Bacterial vaginosis (BV) is the most common vaginal infection affecting women of reproductive age, yet it remains widely misunderstood and frequently undertreated. BV occurs when the natural balance of the vaginal microbiome shifts. Protective Lactobacillus species decrease while anaerobic bacteria, including Gardnerella vaginalis, overgrow.
Unlike traditional sexually transmitted infections, BV is considered a microbial imbalance (dysbiosis). However, sexual activity, particularly with new or multiple partners, can increase risk.
BV is important to address because it can cause persistent symptoms such as unusual discharge, odor, and irritation. It may also increase the risk of pelvic inflammatory disease (PID), raise susceptibility to sexually transmitted infections including HIV, and contribute to pregnancy complications such as preterm birth and low birth weight if left untreated. Because recurrence is common, accurate diagnosis and evidence-based treatment are essential.
Recognizing Symptoms and Knowing When to Seek Care
Common symptoms of BV include thin, grayish-white vaginal discharge, a strong fishy odor that may be more noticeable after sex, mild burning during urination, and vaginal irritation or itching. However, up to half of individuals with BV may not experience noticeable symptoms, which can complicate decisions about testing and treatment.
Medical care should be sought if symptoms are new, worsening, or persistent. Recurrent episodes, defined as more than two or three infections per year, also require medical evaluation. Anyone who is pregnant and experiencing symptoms should seek care promptly. Pelvic pain, fever, or signs of another infection require urgent assessment.
Self-diagnosing BV can lead to confusion with yeast infections or other vaginal conditions, which may delay proper treatment and prolong symptoms.
How Healthcare Providers Diagnose Bacterial Vaginosis
Because BV symptoms overlap with other vaginal infections, healthcare providers use specific clinical criteria and laboratory testing to confirm the diagnosis.
The Amsel criteria are commonly used in clinical settings and require three of four findings: thin homogeneous discharge, vaginal pH greater than 4.5, a positive whiff test (fishy odor when potassium hydroxide is applied), and the presence of clue cells on microscopy.
The Nugent score is a laboratory-based Gram stain scoring system that evaluates bacterial patterns. It is often used in research settings or more complex cases.
Molecular testing, including nucleic acid amplification tests (NAATs), is increasingly available and can detect bacteria associated with BV with greater diagnostic accuracy.
At-Home Testing Versus Clinical Evaluation
At-home BV test kits, such as vaginal pH strips, can detect changes associated with BV and may be helpful for individuals with limited access to care. However, these tests cannot reliably distinguish BV from yeast infections or other vaginal conditions and do not provide a comprehensive clinical assessment.
For first-time symptoms, recurrent infections, pregnancy, or atypical signs, professional evaluation—either in person or through a reputable telehealth provider—is recommended to ensure accurate diagnosis and appropriate treatment.
Evidence-Based Treatment Options for BV
Effective treatment focuses on eliminating harmful bacteria and reducing the risk of recurrence.
Standard first-line therapies include oral metronidazole 500 mg taken twice daily for seven days, metronidazole 0.75 percent vaginal gel used once daily for five days, and clindamycin 2 percent vaginal cream used at bedtime for seven days.
Symptoms often begin to improve within 48 to 72 hours, although complete resolution may take longer. Patients are typically advised to avoid sexual activity or use condoms during treatment and to avoid alcohol during and for 24 hours after completing metronidazole therapy. Completing the full course of medication is essential even if symptoms improve quickly.
For recurrent BV, healthcare providers may prescribe extended or suppressive regimens under medical supervision.
Adjunctive and Alternative Approaches
Probiotics containing specific Lactobacillus strains may help restore vaginal microbiome balance. Research findings are mixed, but some studies suggest probiotics may reduce recurrence when used alongside antibiotic therapy.
In resistant or recurrent cases, clinicians may recommend treatments that target bacterial biofilms, such as boric acid or other specialized vaginal therapies. These should only be used under medical guidance due to potential safety risks if misused.
Emerging treatments, including vaginal microbiome transplantation, are currently under investigation and are not yet considered standard care.
Improving Treatment Adherence and Managing Side Effects
Common side effects of oral metronidazole include a metallic taste and mild gastrointestinal discomfort. Topical treatments may cause localized irritation.
Taking oral medications with food may reduce stomach upset. Following dosing instructions carefully and completing the entire treatment course improves effectiveness. If side effects are problematic, switching between oral and topical formulations may be considered in consultation with a healthcare provider.
Preventing Recurrence
Because recurrence is common, prevention strategies are an important part of BV management.
Avoid douching, as it disrupts the natural vaginal microbiome. Limit the use of scented or intravaginal products that may alter bacterial balance. Consider condom use with new or multiple partners. Wear breathable cotton underwear and avoid prolonged moisture exposure from wet clothing. Managing underlying health conditions, such as uncontrolled diabetes, may also reduce infection risk.
Partner Considerations
Routine treatment of male partners is not generally recommended for uncomplicated BV because research has not shown consistent benefit. However, open communication about symptoms and safe sexual practices may help reduce recurrence risk.
Follow-Up and Monitoring
Follow-up is not always necessary if symptoms fully resolve. However, medical review is recommended if symptoms persist after treatment, recur frequently, or occur during pregnancy. Any signs of complications, such as pelvic pain or fever, require prompt evaluation.
Telehealth follow-up visits may provide a convenient option for confirming symptom resolution and discussing prevention strategies.
When to Seek Specialized or Urgent Care
Urgent medical attention is required if symptoms include pelvic pain, fever, signs of pelvic inflammatory disease, or severe or treatment-resistant infections.
Pregnant individuals experiencing symptoms suggestive of BV should seek prompt obstetric evaluation to reduce the risk of complications.
Conclusion
Bacterial vaginosis is a common and treatable condition that is best managed through accurate diagnosis, evidence-based therapy, and preventive care. Because recurrence is frequent, a comprehensive approach that combines appropriate antibiotics, lifestyle adjustments, and proper follow-up offers the best outcomes.
Seeking timely care from a qualified healthcare provider, whether in person or through telehealth, can reduce delays in treatment and improve recovery. Access to medically reviewed, reliable information empowers individuals to make informed decisions and protect their reproductive health.